144664-11-9 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-2-(4-chlorophenyl)-2-hydroxyacetamide is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique structure allows it to serve as a building block for the development of new medications with potential therapeutic benefits.
Used in Agrochemical Production:
In the agrochemical industry, (S)-2-(4-chlorophenyl)-2-hydroxyacetamide is used as a key component in the production of pesticides and other agricultural chemicals. Its incorporation into these products can enhance their effectiveness in protecting crops and improving overall agricultural yield.
Potential Applications in Medicine:
(S)-2-(4-chlorophenyl)-2-hydroxyacetamide may have potential uses in the medical field, possibly as a therapeutic agent or a component in the development of new treatments for various diseases. However, further research is required to fully understand its properties and potential applications in medicine.
Potential Applications in Biotechnology:
(S)-2-(4-chlorophenyl)-2-hydroxyacetamide may also find applications in the biotechnology sector, where it could be used in the development of new biological products or processes. Its potential use in this field is still under investigation, and more research is needed to determine its full range of properties and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 144664-11-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,6,6 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 144664-11:
(8*1)+(7*4)+(6*4)+(5*6)+(4*6)+(3*4)+(2*1)+(1*1)=129
129 % 10 = 9
So 144664-11-9 is a valid CAS Registry Number.
144664-11-9Relevant academic research and scientific papers
SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1
-
, (2018/01/20)
The invention is directed to substituted pyridine derivatives. Specifically, the invention is directed to compounds according to Formula (Iar): (Iar) wherein Yar, X1ar, X2ar, R1ar, R2ar, R3ar, R4ar and R5ar are as defined herein; or a pharmaceutically acceptable salt or prodrug thereof. The compounds of the invention are selective inhibitors of DNMT1 and can be useful in the treatment of cancer, pre-cancerous syndromes, beta hemoglobinopathy disorders, sickle cell disease, sickle cell anemia, and beta thalassemia, and diseases associated with DNMT1 inhibition. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting DNMT1 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
Biocatalytic reduction of α-keto amides to (R)-α-hydroxy amides using Candida parapsilosis ATCC 7330
Stella, Selvaraj,Chadha, Anju
, p. 345 - 352 (2013/01/15)
Biocatalytic reduction of primary and secondary α-keto amides was accomplished using whole cells of Candida parapsilosis ATCC 7330. The primary (R)-α-hydroxy amides were obtained in good enantiomeric excess (up to 94%) and conversion (88-99%) as compared to the secondary (R)-α-hydroxy amides.
